Investigating the Efficacy and Safety of a Dose-Dense Paclitaxel, Cyclophosphamide With Trastuzumab in Stage I-II Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer. - Elsayed L; Reed E; Modi S; Tandra PK; Copur MS; Samson K; Krishnamurthy J (Clinical breast cancer, 2024)